Related references
Note: Only part of the references are listed.High-dose melphalan and peripheral blood stem cell transplantation for light-chain amyloidosis with cardiac involvement
Sumit Madan et al.
BLOOD (2012)
Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management
Morie A. Gertz
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Quality of Life and Psychological Distress in Hypertrophic Cardiomyopathy Mutation Carriers: A Cross-Sectional Cohort Study
Imke Christiaans et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Systemic Cardiac Amyloidoses Disease Profiles and Clinical Courses of the 3 Main Types
Claudio Rapezzi et al.
CIRCULATION (2009)
Role of the Disease in the Psychological Impact of Pre-Symptomatic Testing for SCA2 and FAP ATTRV30M: Experience with the Disease, Kinship and Gender of the Transmitting Parent
Milena Paneque et al.
JOURNAL OF GENETIC COUNSELING (2009)
Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy
Anita Graceffa et al.
NEUROMUSCULAR DISORDERS (2009)
Psychosocial Determinants of Quality of Life 6 Months After Transplantation: Longitudinal Prospective Study
D. Telles-Correia et al.
TRANSPLANTATION PROCEEDINGS (2009)
Psychiatric differences between liver transplant candidates with familial amyloid polyneuropathy and those with alcoholic liver disease
Diogo Telles-Correia et al.
PROGRESS IN TRANSPLANTATION (2008)
A comparison of health-related quality of life between older adults with heart failure and healthy older adults
Seongkum Heo et al.
HEART & LUNG (2007)
A comparative assessment of the factor structures and psychometric properties of the GHQ-12 and the GHQ-20 based on data from a Finnish population-based sample
Varpu Penninkilampi-Kerola et al.
SCANDINAVIAN JOURNAL OF PSYCHOLOGY (2006)
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
A Dispenzieri et al.
BLOOD (2004)
Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis
A Dispenzieri et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis
G Palladini et al.
CIRCULATION (2003)
Relationship of physical symptoms and physical functioning to depression in patients with heart failure
MM Friedman et al.
HEART & LUNG (2001)
Share Paper
